You are here

Article info

Article menu
Chronic obstructive pulmonary disease
Original article
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

Authors

  1. Correspondence to Professor Neil C Barnes, Respiratory Medical Franchise, GSK, GSK House, 980 Great West Road, Brentford TW8 9GS, UK; neil.c.barnes{at}gsk.com
View Full Text

Citation

Pavord ID, Lettis S, Locantore N, et al
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Thorax 2016;71:118-125.

Publication history

  • Received March 10, 2015
  • Revised September 17, 2015
  • Accepted October 26, 2015
  • First published November 19, 2015.
Online issue publication 
September 01, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/